2026 Q2 Portfolio Activity
In 2026 Q2, Logos Global Management LP maintained a portfolio of 91 distinct positions. The most significant new addition was BIONTECH SE, now representing 4.07% of the total fund value. They heavily accumulated shares in CELLDEX THERAPEUTICS INC NEW, increasing the position by 366.7%. Conversely, Logos Global Management LP completely exited their position in CENTESSA PHARMACEUTICALS PLC.
Position History
hover any row below to update
Loading…
Total Positions
91
Quarter
2026 Q2
Top Holding
ERAS (9.6%)
Top 10 Concentration
48.3%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 91
Logos Global Management LP Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ERAS
ERASCA INC
|
Healthcare | 9.58% | 9.01% |
#1
1
Prev: #2
|
7.8 |
—
|
1,000,000 | 9.0% |
P
S
|
12,150,000 | $222,588,000 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ABVX
ABIVAX SA
|
Healthcare | 5.87% | 3.75% |
#2
5
Prev: #7
|
6.8 |
—
|
349,000 | 51.7% |
P
S
|
1,024,000 | $136,458,240 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 5.64% | 9.71% |
#3
2
Prev: #1
|
3.3 |
—
|
-1,300,000 | -65.0% |
P
S
|
700,000 | $131,096,000 | 2020 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IDYA
IDEAYA BIOSCIEN...
|
Healthcare | 4.81% | 5.74% |
#4
1
Prev: #3
|
2.9 |
—
|
-450,000 | -13.0% |
P
S
|
3,000,000 | $111,810,000 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BNTX
BIONTECH SE
|
Healthcare | 4.07% | — |
#5
Prev: #—
|
5.6 |
—
|
1,015,000 | — |
NEW
|
1,015,000 | $94,445,750 | 2020 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 4.06% | — |
#6
Prev: #—
|
5.1 |
—
|
2,200,000 | — |
NEW
|
2,200,000 | $94,402,000 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 3.84% | 3.13% |
#7
1
Prev: #8
|
2.0 |
—
|
-150,000 | -5.0% |
P
S
|
2,850,000 | $89,091,000 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 3.75% | 4.58% |
#8
4
Prev: #4
|
2.0 |
—
|
-25,000 | -8.8% |
P
S
|
260,000 | $87,045,400 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 3.36% | 0.71% |
#9
32
Prev: #41
|
4.3 |
—
|
1,650,000 | 366.7% |
P
S
|
2,100,000 | $78,141,000 | 2020 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 3.36% | 1.68% |
#10
9
Prev: #19
|
4.3 |
—
|
400,000 | 100.0% |
P
S
|
800,000 | $77,984,000 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CGON
CG ONCOLOGY INC
|
Healthcare | 3.06% | 1.94% |
#11
4
Prev: #15
|
4.2 |
—
|
425,000 | 73.9% |
P
S
|
1,000,000 | $71,050,000 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 2.76% | 1.79% |
#12
6
Prev: #18
|
4.1 |
—
|
315,000 | 56.2% |
P
S
|
875,000 | $63,997,500 | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MAZE
MAZE THERAPEUTI...
|
Healthcare | 2.49% | 1.84% |
#13
3
Prev: #16
|
4.0 |
—
|
700,000 | 56.7% |
P
S
|
1,935,000 | $57,740,400 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 2.44% | 1.27% |
#14
14
Prev: #28
|
4.0 |
—
|
1,150,000 | 82.1% |
P
S
|
2,550,000 | $56,635,500 | 2020 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MLTX
MOONLAKE IMMUNO...
|
Healthcare | 2.24% | 1.40% |
#15
8
Prev: #23
|
3.9 |
—
|
1,175,000 | 78.3% |
P
S
|
2,675,000 | $52,082,250 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
OCUL
OCULAR THERAPEU...
|
Healthcare | 2.24% | 1.63% |
#16
4
Prev: #20
|
3.4 |
—
|
1,450,000 | 37.7% |
P
S
|
5,300,000 | $52,046,000 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DSGN
DESIGN THERAPEU...
|
Healthcare | 1.87% | 1.04% |
#17
15
Prev: #32
|
3.7 |
—
|
1,050,000 | 53.8% |
P
S
|
3,000,000 | $43,410,000 | 2021 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
OLMA
OLEMA PHARMACEU...
|
Healthcare | 1.73% | 2.39% |
#18
8
Prev: #10
|
1.7 |
—
|
no change | no change |
P
S
|
3,208,875 | $40,143,026 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BLTE
BELITE BIO INC
|
Healthcare | 1.66% | — |
#19
Prev: #—
|
4.2 |
—
|
250,000 | — |
NEW
|
250,000 | $38,496,250 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ACHV
ACHIEVE LIFE SC...
|
Healthcare | 1.53% | — |
#20
Prev: #—
|
4.1 |
—
|
5,425,000 | — |
NEW
|
5,425,000 | $35,425,250 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TRVI
TREVI THERAPEUT...
|
Healthcare | 1.51% | 1.43% |
#21
1
Prev: #22
|
0.6 |
—
|
-520,000 | -21.7% |
P
S
|
1,880,000 | $35,062,000 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 1.50% | — |
#22
Prev: #—
|
4.1 |
—
|
900,000 | — |
NEW
|
900,000 | $34,830,000 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AVBP
ARRIVENT BIOPHA...
|
Healthcare | 1.50% | 0.40% |
#23
28
Prev: #51
|
3.6 |
—
|
650,000 | 185.7% |
P
S
|
1,000,000 | $34,740,000 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
CRESCENT BIOPHA...
|
|
Unknown | 1.47% | 0.44% |
#24
25
Prev: #49
|
3.6 |
—
|
1,417,500 | 293.8% |
P
S
|
1,900,000 | $34,200,000 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
CMPS
COMPASS PATHWAY...
|
Healthcare | 1.37% | — |
#25
Prev: #—
|
4.0 |
—
|
2,250,000 | — |
NEW
|
2,250,000 | $31,837,500 | 2020 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 1.22% | — |
#26
Prev: #—
|
4.0 |
—
|
1,050,000 | — |
NEW
|
1,050,000 | $28,329,000 | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
REPL
REPLIMUNE GROUP...
|
Healthcare | 1.19% | — |
#27
Prev: #—
|
4.0 |
—
|
2,500,000 | — |
NEW
|
2,500,000 | $27,675,000 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 1.17% | 1.31% |
#28
2
Prev: #26
|
1.5 |
—
|
no change | no change |
P
S
|
450,000 | $27,162,000 | 2022 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 1.16% | 1.20% |
#29
Prev: #29
|
1.5 |
—
|
no change | no change |
P
S
|
500,000 | $26,835,000 | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 1.10% | 1.33% |
#30
6
Prev: #24
|
0.4 |
—
|
-410,000 | -38.1% |
P
S
|
665,000 | $25,622,450 | 2020 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
JBIO
JADE BIOSCIENCE...
|
Healthcare | 1.08% | 0.28% |
#31
24
Prev: #55
|
3.4 |
—
|
725,000 | 181.2% |
P
S
|
1,125,000 | $24,997,500 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 1.02% | 1.06% |
#32
1
Prev: #31
|
0.9 |
—
|
-75,000 | -13.9% |
P
S
|
465,000 | $23,598,750 | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
VERADERMICS INC
|
|
Unknown | 0.95% | 0.08% |
#33
30
Prev: #63
|
3.4 |
—
|
155,000 | 620.0% |
P
S
|
180,000 | $22,129,200 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 0.91% | 0.22% |
#34
23
Prev: #57
|
3.4 |
—
|
850,000 | 283.3% |
P
S
|
1,150,000 | $21,252,000 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RCUS
ARCUS BIOSCIENC...
|
Healthcare | 0.86% | 1.29% |
#35
8
Prev: #27
|
0.3 |
—
|
-550,000 | -45.8% |
P
S
|
650,000 | $20,039,500 | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SMMT
SUMMIT THERAPEU...
|
Healthcare | 0.85% | — |
#36
Prev: #—
|
3.8 |
—
|
1,350,000 | — |
NEW
|
1,350,000 | $19,669,500 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IMCR
IMMUNOCORE HLDG...
|
Healthcare | 0.82% | 2.26% |
#37
25
Prev: #12
|
0.3 |
—
|
-900,000 | -60.0% |
P
S
|
600,000 | $19,050,000 | 2022 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LBRX
LB PHARMACEUTIC...
|
Healthcare | 0.82% | 1.13% |
#38
8
Prev: #30
|
0.3 |
—
|
-330,000 | -36.1% |
P
S
|
585,000 | $18,986,175 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NERV
MINERVA NEUROSC...
|
Healthcare | 0.79% | 0.97% |
#39
5
Prev: #34
|
0.8 |
—
|
73,777 | 2.3% |
P
S
|
3,288,777 | $18,252,712 | 2019 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SNSE
FAETH THERAPEUT...
|
Healthcare | 0.78% | 0.05% |
#40
24
Prev: #64
|
3.3 |
—
|
692,020 | 2306.7% |
P
S
|
722,020 | $18,050,500 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CRSP
CRISPR THERAPEU...
|
Healthcare | 0.70% | — |
#41
Prev: #—
|
3.8 |
—
|
300,000 | — |
NEW
|
300,000 | $16,362,000 | 2020 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DBVT
DBV TECHNOLOGIE...
|
Healthcare | 0.65% | — |
#42
Prev: #—
|
3.8 |
—
|
915,000 | — |
NEW
|
915,000 | $15,006,000 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
PARABILIS MEDIC...
|
|
Unknown | 0.62% | — |
#43
Prev: #—
|
3.7 |
—
|
525,000 | — |
NEW
|
525,000 | $14,369,250 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 0.60% | 1.95% |
#44
30
Prev: #14
|
0.2 |
—
|
-325,000 | -72.2% |
P
S
|
125,000 | $13,878,750 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VOR
VOR BIOPHARMA I...
|
Healthcare | 0.52% | 0.67% |
#45
2
Prev: #43
|
0.7 |
—
|
-100,000 | -13.3% |
P
S
|
650,000 | $11,966,500 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 0.47% | — |
#46
Prev: #—
|
3.7 |
—
|
200,000 | — |
NEW
|
200,000 | $11,000,000 | 2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IMMX
IMMIX BIOPHARMA...
|
Healthcare | 0.44% | 0.56% |
#47
1
Prev: #46
|
0.7 |
—
|
-225,000 | -18.4% |
P
S
|
1,000,000 | $10,310,000 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
QTTB
Q32 BIO INC
|
Healthcare | 0.44% | — |
#48
Prev: #—
|
3.7 |
—
|
800,000 | — |
NEW
|
800,000 | $10,192,000 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
ODYSSEY THERAPE...
|
|
Unknown | 0.42% | — |
#49
Prev: #—
|
3.7 |
—
|
521,736 | — |
NEW
|
521,736 | $9,761,681 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
ANNX
ANNEXON INC
|
Healthcare | 0.37% | — |
#50
Prev: #—
|
3.6 |
—
|
1,500,000 | — |
NEW
|
1,500,000 | $8,565,000 | 2020 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-50 of 91 holdings